Results 231 to 240 of about 28,669,668 (285)

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

open access: yesMolecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra   +10 more
wiley   +1 more source

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui   +6 more
wiley   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

Inquiry based chemistry instruction

open access: yes, 2015
Maciejowska, Iwona   +2 more
openaire   +1 more source

Inquiry-Based Learning

Encyclopedia of Sustainability in Higher Education, 2010
Department: LLED Copyright Statement of Responsibility This copy was made pursuant to the Fair Dealing Requirements for UBC Faculty and Staff, which may be found at http://copyright.ubc.ca/requirements/fair-dealing/.
Todd Stanley
openaire   +2 more sources

Inquiry-Based Task

Project-Based Learning in the Math Classroom, 2022
Telannia Norfar, Chris Fancher
openaire   +2 more sources

At-Home Colorimetric and Absorbance-Based Analyses: An Opportunity for Inquiry-Based, Laboratory-Style Learning

, 2020
In light of COVID-19 in spring 2020, we developed a simple and versatile inquiry-based, laboratory-style active learning colorimetry experiment amenable to at-home quantitative analysis.
J. Destino, Katie Cunningham
semanticscholar   +1 more source

Evaluation of students’ scientific process skills through reflective worksheets in the inquiry-based learning environments

, 2020
This study aimed to evaluate how 7th-grade students’ scientific process skills changed in the inquiry-based learning environment through reflective worksheets. For this purpose, four inquiry-based activities related to electrical circuits were developed.
Ayfer Mutlu
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy